Enviar noticia por correo electronico

Remitente:
Nombre: Email:
Destinatario:
Nombre: Email:


World's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical

PR News | 28 abr, 2026 14:38